Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationTissue DonorsGraft vs Host DiseaseBone MarrowBone Marrow CellsStem Cell TransplantationTransplantation ChimeraTransplantation ConditioningHematopoietic Stem CellsTransplantation, AutologousWhole-Body IrradiationHistocompatibility TestingStem CellsGraft SurvivalHematologic NeoplasmsLeukemiaAnemia, AplasticTreatment OutcomeBone and BonesHistocompatibilityBusulfanKidney TransplantationHematopoiesisHematopoietic Stem Cell MobilizationLiver TransplantationBone Marrow PurgingSiblingsTransplantationImmunosuppressive AgentsRecurrenceTime FactorsCyclophosphamideGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsGraft RejectionCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLCell DifferentiationLeukemia, Myeloid, AcuteT-LymphocytesTransplantation, IsogeneicRetrospective StudiesDonor SelectionPeripheral Blood Stem Cell TransplantationHepatic Veno-Occlusive DiseaseCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunocompromised HostBone Marrow DiseasesRemission InductionRadiation ChimeraImmunosuppressionAcute DiseaseHematologic DiseasesAntigens, CD34Leukemia, MyeloidHeart TransplantationSurvival AnalysisTransplantation ImmunologyLeukocyte TransfusionOpportunistic InfectionsLymphocyte DepletionColony-Forming Units AssayLiving DonorsSpleenEmbryonic Stem CellsHLA AntigensLymphoma, Non-HodgkinCyclosporineMyelodysplastic SyndromesFlow CytometryMultiple MyelomaBone Marrow ExaminationSurvival RateAdult Stem CellsLung TransplantationMesenchymal Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationChimeraFollow-Up StudiesBone RemodelingGraft vs Host ReactionBone Marrow NeoplasmsCell LineageGraft vs Leukemia EffectFatal OutcomeOrgan TransplantationBlood DonorsSevere Combined ImmunodeficiencyLymphocytesMelphalanAspergillosisMycosesDisease-Free SurvivalChimerismCytomegalovirus